[email protected]
CAS 221877-56-1 42-(2-Tetrazolyl)rapamycin molecular structure lightbox
CAS RN: 221877-56-1

42-(2-Tetrazolyl)rapamycin

Product Availability

Choose a grade to view its available package options.

1 package records0 with current stock1 grade group
Batch No.PackageAvailabilityLead TimeInquiry
Batchno.20251007 5mg Out of stock 5-7 business days Inquiry
  • Product code: starshine_CAS221877-56-1
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

221877-56-1 / (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-12-[(2R)-1-[(1S,3R,4S)-3-methoxy-4-(tetrazol-2-yl)cyclohexyl]propan-2-yl]-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone

Standard CAS: 221877-56-1 Multi CAS: No
Basic Information Computed Properties

Basic Information

CAS
221877-56-1
Multi CAS
No
Molecular Formula
C52H79N5O12
Molecular Weight
966.200000
Exact Mass
965.572523
SMILES
C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@@H]([C@@H](C4)OC)N5N=CN=N5)C)/C)O)OC)C)C)/C)OC
InChI
InChI=1S/C52H79N5O12/c1-31-16-12-11-13-17-32(2)43(65-8)28-39-21-19-37(7)52(64,69-39)49(61)50(62)56-23-15-14-18-41(56)51(63)68-44(34(4)26-38-20-22-40(45(27-38)66-9)57-54-30-53-55-57)29-42(58)33(3)25-36(6)47(60)48(67-10)46(59)35(5)24-31/h11-13,16-17,25,30-31,33-35,37-41,43-45,47-48,60,64H,14-15,18-24,26-29H2,1-10H3/b13-11+,16-12+,32-17+,36-25+/t31-,33-,34-,35-,37-,38+,39+,40+,41+,43+,44+,45-,47-,48+,52-/m1/s1
InChIKey
IURNHYDSJVLLPN-JUKNQOCSSA-N

Computed Properties

Structural Parameters

Heavy atom count
69
Aromatic heavy atom count
5
Fraction Csp3
0.73
Rotatable bonds
7
H-bond acceptors
16
H-bond donors
2
Molar refractivity
255.98
TPSA
218.8

LogP / Solubility

WLOGP
6.05
MLOGP
5.41
XLogP3
6.5
Consensus LogP
5.99
Log S (ESOL)
-9.23
Class (ESOL)
Insoluble
Log S (Ali)
-11.85
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-11.8
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-4.32

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
10

Customers Also Viewed

Get In Touch

Contact Us